ChartMill assigns a Buy % Consensus number of 80% to CTXR. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-04 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-08-13 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-30 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-10 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-09 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-05-23 | Maxim Group | Downgrade | Buy -> Hold |
| 2025-05-15 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-02-18 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-01-07 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-12-30 | D. Boral Capital | Upgrade | Hold -> Buy |
| 2024-11-22 | D. Boral Capital | Downgrade | Buy -> Hold |
| 2024-11-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-11 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-08-19 | EF Hutton | Maintains | Buy -> Buy |
| 2024-08-08 | EF Hutton | Maintains | Buy -> Buy |
| 2024-08-05 | EF Hutton | Maintains | Buy -> Buy |
| 2024-07-15 | EF Hutton | Initiate | Buy |
| 2024-05-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-02-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-01 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-05-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-04-03 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-29 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-01-18 | HC Wainwright & Co. | Maintains | Buy |
| 2021-11-30 | Maxim Group | Initiate | Buy |
9 analysts have analysed CTXR and the average price target is 5.1 USD. This implies a price increase of 473.03% is expected in the next year compared to the current price of 0.89.
The consensus rating for CITIUS PHARMACEUTICALS INC (CTXR) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.